The effect of moderate alcohol consumption on nonalcoholic fatty liver disease.
作者信息
Park Ji-Won, Suk Ki Tae
机构信息
Institute for Liver and Digestive Diseases, Hallym University, Chuncheon, Korea.
Department of Internal Medicine, Hallym University Sacred Heart Hospital of Hallym University Medical Center, Anyang, Korea.
出版信息
Clin Mol Hepatol. 2023 Apr;29(2):408-410. doi: 10.3350/cmh.2023.0085. Epub 2023 Mar 16.
Abstract
摘要
相似文献
1
The effect of moderate alcohol consumption on nonalcoholic fatty liver disease.适度饮酒对非酒精性脂肪性肝病的影响。
Clin Mol Hepatol. 2023 Apr;29(2):408-410. doi: 10.3350/cmh.2023.0085. Epub 2023 Mar 16.
2
Effects of Moderate Alcohol Drinking in Patients with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者适度饮酒的影响。
Gut Liver. 2019 May 15;13(3):308-314. doi: 10.5009/gnl18175.
3
The effects of moderate alcohol consumption on non-alcoholic fatty liver disease.适量饮酒对非酒精性脂肪肝的影响。
Clin Mol Hepatol. 2023 Feb;29(Suppl):S261-S267. doi: 10.3350/cmh.2022.0393. Epub 2022 Dec 22.
4
The effect of moderate alcohol drinking in nonalcoholic fatty liver disease.非酒精性脂肪肝中适量饮酒的影响。
Clin Mol Hepatol. 2020 Oct;26(4):662-669. doi: 10.3350/cmh.2020.0163. Epub 2020 Sep 25.
5
[Diagnosis and treatment strategies for fatty liver when obesity coexists with alcohol consumption].肥胖与饮酒并存时脂肪肝的诊断与治疗策略
Zhonghua Gan Zang Bing Za Zhi. 2020 Mar 20;28(3):212-216. doi: 10.3760/cma.j.cn501113-20200317-00122.
6
Low alcohol consumption increases the risk of impaired glucose tolerance in patients with non-alcoholic fatty liver disease.低酒精摄入量会增加非酒精性脂肪性肝病患者糖耐量受损的风险。
J Gastroenterol. 2016 Nov;51(11):1090-1100. doi: 10.1007/s00535-016-1194-0. Epub 2016 Mar 12.
7
Moderate alcohol consumption is associated with advanced fibrosis in non-alcoholic fatty liver disease and shows a synergistic effect with type 2 diabetes mellitus.适量饮酒与非酒精性脂肪性肝病的肝纤维化进展有关，并且与 2 型糖尿病有协同作用。
Metabolism. 2021 Feb;115:154439. doi: 10.1016/j.metabol.2020.154439. Epub 2020 Nov 25.
8
ADH1B∗2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption.ADH1B∗2 与非酒精性脂肪性肝病严重程度降低相关，与酒精摄入无关。
Gastroenterology. 2020 Sep;159(3):929-943. doi: 10.1053/j.gastro.2020.05.054. Epub 2020 May 23.
9
Drinking and Obesity: Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Interactions.饮酒与肥胖：酒精性肝病/非酒精性脂肪性肝病的相互作用。
Semin Liver Dis. 2020 May;40(2):154-162. doi: 10.1055/s-0040-1701443. Epub 2020 Feb 18.
10
Nonheavy Drinking and Worsening of Noninvasive Fibrosis Markers in Nonalcoholic Fatty Liver Disease: A Cohort Study.非重度饮酒与非酒精性脂肪性肝病患者无创性纤维化标志物恶化的关系：一项队列研究。
Hepatology. 2019 Jan;69(1):64-75. doi: 10.1002/hep.30170. Epub 2018 Dec 26.
引用本文的文献
1
Dynamic Status of Systemic Immune Inflammation Index Is Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: An Evidence From a Ten-Year Prospective Longitudinal Cohort Study.全身免疫炎症指数的动态状态与代谢功能障碍相关脂肪性肝病有关：一项十年前瞻性纵向队列研究的证据
J Inflamm Res. 2025 Apr 1;18:4595-4606. doi: 10.2147/JIR.S509814. eCollection 2025.
2
Akkermansia muciniphila improve cognitive dysfunction by regulating BDNF and serotonin pathway in gut-liver-brain axis.阿克曼氏菌（Akkermansia muciniphila）通过调节肠-肝-脑轴中的 BDNF 和血清素途径改善认知功能障碍。
Microbiome. 2024 Sep 28;12(1):181. doi: 10.1186/s40168-024-01924-8.
3
Alcohol Drinking Impacts on Adiposity and Steatotic Liver Disease: Concurrent Effects on Metabolic Pathways and Cardiovascular Risks.饮酒对肥胖和脂肪性肝病的影响：对代谢途径和心血管风险的共同影响。
Curr Obes Rep. 2024 Sep;13(3):461-474. doi: 10.1007/s13679-024-00560-5. Epub 2024 Mar 23.
4
Unraveling the Connection between Fatty Liver Severity with Gender, Lifestyle, and Health Risks among Workers.解析脂肪肝严重程度与工人性别、生活方式和健康风险之间的关系。
Nutrients. 2023 Nov 13;15(22):4765. doi: 10.3390/nu15224765.
本文引用的文献
1
The effects of moderate alcohol consumption on non-alcoholic fatty liver disease.适量饮酒对非酒精性脂肪肝的影响。
Clin Mol Hepatol. 2023 Feb;29(Suppl):S261-S267. doi: 10.3350/cmh.2022.0393. Epub 2022 Dec 22.
2
Identification of high-risk subjects in nonalcoholic fatty liver disease.非酒精性脂肪性肝病高危人群的识别。
Clin Mol Hepatol. 2023 Feb;29(Suppl):S196-S206. doi: 10.3350/cmh.2022.0431. Epub 2022 Dec 5.
3
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease.KASL临床实践指南：非酒精性脂肪性肝病的管理
Clin Mol Hepatol. 2021 Jul;27(3):363-401. doi: 10.3350/cmh.2021.0178. Epub 2021 Jun 22.
4
Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD - Reconciling the present with the past.从19世纪的脂肪肝到当代非酒精性脂肪性肝病的历史叙事——调和过去与现在。
JHEP Rep. 2021 Feb 26;3(3):100261. doi: 10.1016/j.jhepr.2021.100261. eCollection 2021 Jun.
5
Risks of Light and Moderate Alcohol Use in Fatty Liver Disease: Follow-Up of Population Cohorts.在脂肪肝疾病中，轻度和中度饮酒的风险：人群队列的随访。
Hepatology. 2020 Mar;71(3):835-848. doi: 10.1002/hep.30864. Epub 2019 Oct 8.
6
Non-alcoholic fatty liver disease - A global public health perspective.非酒精性脂肪性肝病——全球公共卫生视角。
J Hepatol. 2019 Mar;70(3):531-544. doi: 10.1016/j.jhep.2018.10.033. Epub 2018 Nov 9.
7
Nonheavy Drinking and Worsening of Noninvasive Fibrosis Markers in Nonalcoholic Fatty Liver Disease: A Cohort Study.非重度饮酒与非酒精性脂肪性肝病患者无创性纤维化标志物恶化的关系：一项队列研究。
Hepatology. 2019 Jan;69(1):64-75. doi: 10.1002/hep.30170. Epub 2018 Dec 26.
8
Alcohol consumption in late adolescence is associated with an increased risk of severe liver disease later in life.青少年晚期饮酒与成年后患严重肝脏疾病的风险增加有关。
J Hepatol. 2018 Mar;68(3):505-510. doi: 10.1016/j.jhep.2017.11.019. Epub 2018 Jan 22.
9
Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis.在非酒精性脂肪性肝病患者中，适度饮酒与肝组织脂肪变性和脂肪性肝炎改善程度较小相关。
Clin Gastroenterol Hepatol. 2018 Sep;16(9):1511-1520.e5. doi: 10.1016/j.cgh.2018.01.026. Epub 2018 Mar 14.
10
Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population.饮酒与代谢综合征在预测普通人群严重肝脏疾病中的相互作用。
Hepatology. 2018 Jun;67(6):2141-2149. doi: 10.1002/hep.29631. Epub 2018 Apr 16.
Zotero 插件